Investor Stock List
Ranked #1,603 of 8,699 institutional investors

Casdin Capital, LLC

New York, NY

$1.83B
US stock portfolio at live prices · today −$709K (−0.04%)
Live prices, last trade 9:55 AM ET
Value at quarter end (Q3 2026)
$2.30B
Change from Q2 2026
+$297.9M (+14.91%)
Positions
46 · 7 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$178M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
RVMD 23.0%RLAY 13.9%WGS 9.81%ILMN 5.71%GRAL 3.77%
StockSharesValue, live% of portfoliovs Q2 2026
RVMD Revolution Medicines, Inc.2,577,333$422M23.0%Unchanged
RLAY Relay Therapeutics, Inc.16,035,240$254M13.9%Unchanged
WGS GeneDx Holdings Corp.3,707,164$180M9.81%Unchanged
ILMN Illumina, Inc.530,000$105M5.71%Unchanged
GRAL GRAIL, Inc.680,000$69.0M3.77%Added +42%
TXG 10x Genomics, Inc.1,050,000$56.7M3.09%Unchanged
LAB Standard BioTools Inc.88,783,856$53.6M2.92%Unchanged
SRRK Scholar Rock Holding Corporation850,000$43.6M2.38%Added +28%
NGNE Neurogene Inc.1,585,361$35.8M1.95%Added +3%
PSNL Personalis, Inc.2,300,000$33.3M1.82%Reduced −10%
BEAM Beam Therapeutics Inc.1,500,000$32.4M1.77%Added +11%
MAZE Maze Therapeutics, Inc.843,857$27.1M1.48%Unchanged
GH Guardant Health, Inc.185,000$26.4M1.44%Unchanged
SRPT Sarepta Therapeutics, Inc.1,820,000$25.9M1.41%Added +287%
TEM Tempus AI, Inc.423,597$24.2M1.32%New
DNLI Denali Therapeutics Inc.1,250,000$23.2M1.26%Reduced −39%
SEPN Septerna, Inc.553,268$21.6M1.18%Unchanged
PBLS Parabilis Medicines, Inc.645,690$18.2M0.99%Unchanged
ALNY Alnylam Pharmaceuticals, Inc.120,000$17.9M0.98%Added +60%
GPCR Structure Therapeutics Inc.1,030,000$17.4M0.95%Reduced −12%
MRNA Moderna, Inc.75,000$15.6M0.85%Unchanged
TSHA Taysha Gene Therapies, Inc.3,900,000$14.6M0.80%Added +20%
DGX Quest Diagnostics Incorporated50,000$13.1M0.71%Unchanged
HIMS Hims & Hers Health, Inc.800,000$12.6M0.69%Added +14%
BIIB Biogen Inc.50,000$12.5M0.68%New
PRME Prime Medicine, Inc.3,167,175$12.1M0.66%Unchanged
ANL Adlai Nortye Group Ltd.1,250,000$11.3M0.62%Unchanged
EWTX Edgewise Therapeutics, Inc.265,000$10.8M0.59%New
ORIC ORIC Pharmaceuticals, Inc.1,250,000$9.8M0.54%New
AGMB AgomAb Therapeutics NV1,550,000$8.5M0.46%Unchanged
ABSI Absci Corporation973,260$7.8M0.43%Unchanged
BRVE Braveheart Bio, Inc.400,000$7.8M0.43%New
BNTX BioNTech SE85,000$7.0M0.38%New
VCYT Veracyte, Inc.276,308$6.9M0.38%Unchanged
RAPP Rapport Therapeutics, Inc.200,000$4.7M0.26%New
NTLA Intellia Therapeutics, Inc.355,000$3.6M0.20%Unchanged
IPSC Century Therapeutics, Inc.1,228,190$1.6M<0.1%Unchanged
CTNM Contineum Therapeutics, Inc.148,333$1.3M<0.1%Unchanged
PACB Pacific Biosciences of California, Inc.723,767$1.2M<0.1%Unchanged
EDIT Editas Medicine, Inc.445,000$772K<0.1%Unchanged
GLUE Monte Rosa Therapeutics, Inc.86,014$765K<0.1%Reduced −54%
KARD Kardigan, Inc.50,000$621K<0.1%Unchanged
BBOT BridgeBio Oncology Therapeutics, Inc.282,312$529K<0.1%Unchanged
RXRX Recursion Pharmaceuticals, Inc.165,323$446K<0.1%Unchanged
DNA Ginkgo Bioworks Holdings, Inc.36,493$290K<0.1%Unchanged
TNYA Tenaya Therapeutics, Inc.361,969$109K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
IRON Disc Medicine, Inc.65,000$4.9M
SION Sionna Therapeutics, Inc.400,000$1.2M